Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleischer, N.
Right arrow Articles by Efrat, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fleischer, N.
Right arrow Articles by Efrat, S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 47, Issue 9 1419-1425, Copyright © 1998 by American Diabetes Association


ARTICLES

Functional analysis of a conditionally transformed pancreatic beta-cell line

N Fleischer, C Chen, M Surana, M Leiser, L Rossetti, W Pralong and S Efrat
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA. fleisch@aecom.yu.edu

Development of beta-cell lines for cell therapy of diabetes is hindered by functional deviations of the replicating cells from the normal beta-cell phenotype. In a recently developed cell line, denoted betaTC-tet, derived from transgenic mice expressing the SV40 T antigen (Tag) under control of the tetracycline (Tc) gene regulatory system, growth arrest can be induced by shutting off Tag expression in the presence of Tc. Here, we compared differentiated cell functions in dividing and growth-arrested betaTC-tet cells, both in culture and in vivo. Proliferating cells stably maintained normal glucose responsiveness for >60 passages in culture. Growth-arrested cells survived for months in culture and in vivo and maintained normal insulin production and secretion. After growth arrest, the cells gradually increased their insulin content three- to fourfold. This occurred without significant changes in insulin biosynthetic rates. At high passage numbers, proliferating betaTC-tet cells exhibited an abnormal increase in hexokinase expression. However, the upregulation of hexokinase was reversible upon growth arrest. Growth-arrested cells transplanted intraperitoneally into syngeneic recipients responded to hyperglycemia by a significant increase in insulin secretion. These findings demonstrate that transformed beta-cells maintain function during long periods of growth arrest, suggesting that conditional transformation of beta-cells may be a useful approach for developing cell therapy for diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
S. Klinger, C. Poussin, M.-B. Debril, W. Dolci, P. A. Halban, and B. Thorens
Increasing GLP-1-Induced {beta}-Cell Proliferation by Silencing the Negative Regulators of Signaling cAMP Response Element Modulator-{alpha} and DUSP14
Diabetes, March 1, 2008; 57(3): 584 - 593.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. S. Narang and R. I. Mahato
Biological and biomaterial approaches for improved islet transplantation.
Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-Y. Yang, J. Walicki, A. Abderrahmani, M. Cornu, G. Waeber, B. Thorens, and C. Widmann
Expression of an Uncleavable N-terminal RasGAP Fragment in Insulin-secreting Cells Increases Their Resistance toward Apoptotic Stimuli without Affecting Their Glucose-induced Insulin Secretion
J. Biol. Chem., September 23, 2005; 280(38): 32835 - 32842.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Zalzman, L. Anker-Kitai, and S. Efrat
Differentiation of Human Liver-Derived, Insulin-Producing Cells Toward the {beta}-Cell Phenotype
Diabetes, September 1, 2005; 54(9): 2568 - 2575.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Zalzman, S. Gupta, R. K. Giri, I. Berkovich, B. S. Sappal, O. Karnieli, M. A. Zern, N. Fleischer, and S. Efrat
Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells
PNAS, June 10, 2003; 100(12): 7253 - 7258.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. R. Laybutt, G. C. Weir, H. Kaneto, J. Lebet, R. D. Palmiter, A. Sharma, and S. Bonner-Weir
Overexpression of c-Myc in {beta}-Cells of Transgenic Mice Causes Proliferation and Apoptosis, Downregulation of Insulin Gene Expression, and Diabetes
Diabetes, June 1, 2002; 51(6): 1793 - 1804.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Metz, S. Holland, L. Johnson, E. Espling, M. Rabaglia, V. Segu, J. S. Brockenbrough, and P. O. Tran
Inosine-5'-Monophosphate Dehydrogenase Is Required for Mitogenic Competence of Transformed Pancreatic {beta} Cells
Endocrinology, January 1, 2001; 142(1): 193 - 204.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-C. Jonas, A. Sharma, W. Hasenkamp, H. Ilkova, G. Patane, R. Laybutt, S. Bonner-Weir, and G. C. Weir
Chronic Hyperglycemia Triggers Loss of Pancreatic beta  Cell Differentiation in an Animal Model of Diabetes
J. Biol. Chem., May 14, 1999; 274(20): 14112 - 14121.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Dupraz, S. Cottet, F. Hamburger, W. Dolci, E. Felley-Bosco, and B. Thorens
Dominant Negative MyD88 Proteins Inhibit Interleukin-1beta /Interferon-gamma -mediated Induction of Nuclear Factor kappa B-dependent Nitrite Production and Apoptosis in beta Cells
J. Biol. Chem., November 22, 2000; 275(48): 37672 - 37678.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1998 by the American Diabetes Association.